Cargando…

ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides

Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT. Immediate or late hemolytic reactions, pure red cell aplasia, delayed red blood cell recovery, and graft-versus -host disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokrgozar, Negin, Tamaddon, Gholamhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375375/
https://www.ncbi.nlm.nih.gov/pubmed/30774834
_version_ 1783395364907253760
author Shokrgozar, Negin
Tamaddon, Gholamhossein
author_facet Shokrgozar, Negin
Tamaddon, Gholamhossein
author_sort Shokrgozar, Negin
collection PubMed
description Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT. Immediate or late hemolytic reactions, pure red cell aplasia, delayed red blood cell recovery, and graft-versus -host disease are the results of this situation. This review shows the consequences of ABO-mismatched HSCT and its impacts on HSCT parameters, as well as providing clinical guides in this situation.
format Online
Article
Text
id pubmed-6375375
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-63753752019-02-15 ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides Shokrgozar, Negin Tamaddon, Gholamhossein Int J Hematol Oncol Stem Cell Res Review Article Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT. Immediate or late hemolytic reactions, pure red cell aplasia, delayed red blood cell recovery, and graft-versus -host disease are the results of this situation. This review shows the consequences of ABO-mismatched HSCT and its impacts on HSCT parameters, as well as providing clinical guides in this situation. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018-10-01 /pmc/articles/PMC6375375/ /pubmed/30774834 Text en Copyright : © International Journal of Hematology-Oncology and Stem Cell Research & Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Shokrgozar, Negin
Tamaddon, Gholamhossein
ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides
title ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides
title_full ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides
title_fullStr ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides
title_full_unstemmed ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides
title_short ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides
title_sort abo blood grouping mismatch in hematopoietic stem cell transplantation and clinical guides
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375375/
https://www.ncbi.nlm.nih.gov/pubmed/30774834
work_keys_str_mv AT shokrgozarnegin abobloodgroupingmismatchinhematopoieticstemcelltransplantationandclinicalguides
AT tamaddongholamhossein abobloodgroupingmismatchinhematopoieticstemcelltransplantationandclinicalguides